Revenue - Additional Information (Details) $ in Thousands	1 Months Ended		3 Months Ended
	Oct. 31, 2021 USD ($)	Jul. 31, 2021 USD ($)	Mar. 31, 2022 USD ($) Segment	Mar. 31, 2021 USD ($)	Apr. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Disaggregation Of Revenue [Line Items]
Number of reportable segments | Segment			1
Revenues			$ 0
Net accounts receivable from customers			2,599			$ 183
RADx Initiative
Disaggregation Of Revenue [Line Items]
Revenue received in completion of second stage			700	$ 7,000
Potential milestone payment	$ 2,000	$ 4,000
Term of contract	Jan. 30, 2022
NIH
Disaggregation Of Revenue [Line Items]
Additional funding available under extension					$ 1,100
Grant revenue recognized			$ 200	$ 0
Minimum
Disaggregation Of Revenue [Line Items]
Percentage of product revenue			10.00%